Jonathan Juco

23 papers receiving 2.6k citations

Jonathan Juco's Hit Papers

Clinical Utility of the Combined Positive Score for Programmed Death Ligand-1 Expression and the Approval of Pembrolizumab for Treatment of Gastric Cancer 2018 · 390 citations
3900+3+6Years since publication250500750

Peers

Jonathan Juco
Comparison fields: 5 of 79
  • Oncology 1.5k
  • Gastroenterology 144
  • Immunology 487
  • Pulmonary and Respiratory Medicine 702
  • Pathology and Forensic Medicine 312
Replace Armelle Dufresne with:
Armelle Dufresne France
Tatsuya Yoshida Japan
H Arnholdt Germany
Federica Bertolini Italy
Kevin Norwood United States
Hiromasa Fujita Japan
Akira Fukutomi Japan
Paola Casieri Italy
Bernadette Liegl‐Atzwanger Austria
Kenneth Cardona United States
Jonathan Juco relative to Armelle Dufresne France Armelle Dufresne's profile →
Citations per field
00.5×4.0×
Armelle Dufresne · 1×
Citations per year

Countries citing papers authored by Jonathan Juco

Since Specialization
Citations

This map shows the geographic impact of Jonathan Juco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Juco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Juco more than expected).

Fields of papers citing papers by Jonathan Juco

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Juco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Juco. The network helps show where Jonathan Juco may publish in the future.

Co-authors

The 25 scholars most cited alongside Jonathan Juco, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jonathan Juco Line = papers co-authored together Jonathan Juco links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial
Hit paper breakdown →
2016854
2
PD-L2 Expression in Human Tumors: Relevance to Anti-PD-1 Therapy in Cancer
Hit paper breakdown →
2017464
3
Clinical Utility of the Combined Positive Score for Programmed Death Ligand-1 Expression and the Approval of Pembrolizumab for Treatment of Gastric Cancer
Hit paper breakdown →
2018390
4
Safety and activity of pembrolizumab in patients with locally advanced or metastatic urothelial cancer (KEYNOTE-012): a non-randomised, open-label, phase 1b study
Hit paper breakdown →
2017261
5 201590
6 201780
7 201769
8 201865
9 200365
10 200851
11 200444
12 200041
13 200440
14 200032
15 200822
16 200315
17 200913
18 201811
19 20078
20 20076

About Jonathan Juco

Jonathan Juco is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, Surgery and Neurology, having authored 24 papers that have together received 2.6k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (10 papers), Lymphoma Diagnosis and Treatment (4 papers), CNS Lymphoma Diagnosis and Treatment (3 papers), Radiomics and Machine Learning in Medical Imaging (3 papers), Immune Cell Function and Interaction (2 papers), CAR-T cell therapy research (2 papers), Bladder and Urothelial Cancer Treatments (2 papers) and Acute Myeloid Leukemia Research (2 papers). The work is most often cited by research in Oncology (1.5k citations), Gastroenterology (144 citations), Immunology (487 citations), Pulmonary and Respiratory Medicine (702 citations) and Pathology and Forensic Medicine (312 citations). Jonathan Juco has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Jared Lunceford, Kenneth Emancipator, Shilpa Gupta, Laura Q.M. Chow, Kumudu Pathiraja, Barbara Burtness, Yung‐Jue Bang, Joseph P. Eder, Chia‐Chi Lin and Daniel V.T. Catenacci. Their work appears in journals such as American Journal of Clinical Pathology, Journal of Clinical Oncology, Endocrine Pathology, The Lancet Oncology and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact